Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

NCT00974012 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Divalproex Sodium
DRUG: Depakote®

Sponsor

Teva Pharmaceuticals USA